Aurelia de Vries Schultink's PhD research at the Netherlands Cancer Institute shows, among other things, that such farmacometric models can improve the treatment with existing cancer drugs, such as tamoxifen. Also, they are very useful for determining the right doses of new drugs in a clinical trial. She will defend her thesis at Utrecht University on Wednesday May 29th. Good luck Aurelia!
Practical information about the defense can be found on Utrecht University's website.